Amoxicillin-Methotrexate Interaction Guidelines

Introduction to Interaction Risks

The British Association of Dermatologists guidelines state that penicillins, such as amoxicillin, can increase methotrexate levels, particularly with high-dose methotrexate, but this does not appear to be a significant issue in clinical practice for low-dose regimens 1

Elderly patients are at increased risk of methotrexate accumulation due to age-related decline in renal function, according to the British Journal of Dermatology 1 and Praxis Medical Insights 2
Patients with renal impairment are substantially more likely to experience interactions, as stated by the British Journal of Dermatology 1

The interaction between amoxicillin and methotrexate occurs through reduced renal elimination of methotrexate, as amoxicillin competes with methotrexate at the renal tubular secretion system, according to the British Journal of Dermatology 1

The British Association of Dermatologists recommends assessing renal function before prescribing amoxicillin to patients already on methotrexate, and considering alternative antibiotics when feasible 1
For patients on high-dose methotrexate, the guidelines suggest stopping methotrexate until the patient recovers and the antibiotic course is complete, while for low-risk patients, methotrexate can be continued with enhanced monitoring 1

The British Journal of Dermatology and Praxis Medical Insights recommend monitoring CBC and liver function tests every 2-4 weeks initially, and checking renal function every 2-3 months, or more frequently if risk factors are present 1, 2
Patients should be educated on signs of toxicity, including unusual bruising or bleeding, mouth sores, severe nausea/vomiting, and dark urine or signs of renal dysfunction, as stated by Praxis Medical Insights 2

The British Journal of Dermatology recommends that most antibiotics are safe to prescribe with methotrexate, but trimethoprim-sulfamethoxazole at therapeutic doses must be avoided entirely due to severe risk of pancytopenia and mucositis, while penicillins, tetracyclines, and ciprofloxacin can be used safely with appropriate monitoring 3

Penicillins can be used safely in patients on low-dose methotrexate for dermatologic or rheumatologic conditions, with monitoring for potential interactions 3
Tetracyclines are safe for use with methotrexate, with listed potential interactions in high-dose methotrexate contexts, but not clinically significant in practice for low-dose regimens 3
Ciprofloxacin is safe to prescribe with methotrexate, showing a favorable safety profile even in complex patient populations 3, 4

Methotrexate should be stopped if antibiotics are prescribed for severe infections, infections not responding to standard treatment, and resumed only after the patient recovers and completes the antibiotic course 3

The British Journal of Dermatology advises against confusing low-dose methotrexate with high-dose methotrexate, as most interaction data comes from high-dose studies and does not apply to rheumatologic/dermatologic dosing 3
The British Journal of Dermatology also advises against automatically stopping methotrexate for routine infections, only severe or refractory infections warrant stopping, and against prescribing probenecid concurrently, as it inhibits renal tubular secretion and dramatically increases methotrexate toxicity 3

The American Academy of Dermatology suggests that sulfonamides can decrease methotrexate binding to albumin and reduce renal tubular excretion, leading to increased serum methotrexate levels, and serious toxic reactions can occur with concomitant use 5
The American Academy of Dermatology recommends that patients on low-dose methotrexate can safely use certain antibiotics, such as tetracyclines and ciprofloxacin, with appropriate monitoring 5

The British Medical Journal warns that trimethoprim-sulfamethoxazole (Bactrim) poses a significant risk of pancytopenia, mucositis, and renal toxicity, and should be avoided entirely in patients on methotrexate 6, 7
The British Medical Journal advises that probenecid should not be prescribed concurrently with methotrexate, as it inhibits renal tubular secretion and dramatically increases methotrexate toxicity 6, 7

The American Academy of Dermatology recommends that patients on methotrexate should have their renal function assessed before prescribing any antibiotic, as declining renal function is the most important predictor of methotrexate toxicity 5
The American Academy of Dermatology suggests that high-risk patients, such as the elderly and those with renal impairment, require enhanced monitoring when prescribed antibiotics that may interact with methotrexate 5

The American Academy of Dermatology and the British Medical Journal warn that NSAIDs, such as salicylates, naproxen, ibuprofen, and indomethacin, can increase methotrexate toxicity and should be used with caution 5, 6, 7